The BaseScope™ VS Reagent Kit is designed to be automated on the DISCOVERY ULTRA Automated IHC/ISH slide staining systems from Roche Tissue Diagnostics. The BaseScope™ Assay leverages the same platform as proven and established within the RNAscope® technology but expands the detection capabilities, enabling the detection of short RNA target sequences and exon junctions in cells and tissues with morphological context, providing new data dimensions and unique insight into biological mechanisms.

The BaseScope™ VS Reagent Kit, with its high contrast Fast Red dye, is the first choice in in situ hybridization applications where chromogenic staining with DAB is less desirable (i.e. staining of highly pigmented lung, liver, retina and melanoma tissue specimens). Also, for genes where a lower expression is assumed, ACD recommends this kit, as the red dots clearly distinguish against the hematoxylin staining and visible under standard brightfield microscope.

Sample Images


 

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified proteins:notably cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds and ACD's in situ hybridization detection products,which are sold to biomedical researchers and clinical research laboratories; these operations constitute the core Biotechnology Division, headquartered in Minneapolis, Minnesota. The Protein Platforms Division manufactures innovative protein analysis tools under the ProteinSimple brand name that greatly automate western blotting and immunoassay practices. The Diagnostics Division manufactures FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM customer and clinical customers. Bio-Techne products are integral components of scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $563 million in net sales in fiscal 2017 and has approximately 1,800 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio-techne.com.